Crystalvue Medical Corporation (TPEX:6527)

Market Cap	1.79B -16.4%
Revenue (ttm)	949.05M +9.3%
Net Income	146.98M +15.6%
EPS	5.70 +15.2%
Shares Out	25.34M
PE Ratio	12.37
Forward PE	n/a
Dividend	2.90 (4.11%)
Ex-Dividend Date	Jul 24, 2025

Volume	1,000
Average Volume	28,968
Open	70.50
Previous Close	70.50
Day's Range	69.20 - 70.50
52-Week Range	69.30 - 93.00
Beta	0.84
RSI	40.97
Earnings Date	May 11, 2026

About Crystalvue Medical

Crystalvue Medical Corporation manufactures and sells medical devices worldwide. The company offers optical coherence tomography, retinal cameras, tonometers, lens edgers, and gastroenterology supplies, as well as ODM/OEM services for automated nucleic acid extraction instrument and PCR system. It also sells minimal invasive endoscopic instrument supplies. The company was founded in 2009 and is based in Taoyuan City, Taiwan.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2009
• Employees: 109
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6527

Financial Performance

In 2025, Crystalvue Medical's revenue was 949.05 million, an increase of 9.33% compared to the previous year's 868.03 million. Earnings were 146.98 million, an increase of 15.59%.